Orchestra BioMed Holdings, Inc. Increase (Decrease) in Accrued Liabilities
Orchestra BioMed Holdings, Inc. (OBIO) reported Increase (Decrease) in Accrued Liabilities of $1.35 million for the 12-month period ending 2022-12-31, per its 10-K filed 2023-01-25.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccruedLiabilities · last filed 2023-01-25
- Orchestra BioMed Holdings, Inc. increase (decrease) in accrued liabilities for the quarter ending 2022-12-31 was $207.88K.
- Orchestra BioMed Holdings, Inc. increase (decrease) in accrued liabilities for the quarter ending 2022-09-30 was $231.95K.
- Orchestra BioMed Holdings, Inc. increase (decrease) in accrued liabilities for the quarter ending 2022-06-30 was $724.07K, a 12708.60% increase year-over-year.
- Orchestra BioMed Holdings, Inc. increase (decrease) in accrued liabilities for the quarter ending 2022-03-31 was $188.78K, a 3865.97% increase year-over-year.
- Orchestra BioMed Holdings, Inc. increase (decrease) in accrued liabilities for fiscal 2022 was $1.35M.
- Orchestra BioMed Holdings, Inc. increase (decrease) in accrued liabilities for fiscal 2021 was -$60.99K.
| Period end | Increase (Decrease) in Accrued Liabilities 1 month | Increase (Decrease) in Accrued Liabilities 3 month | Increase (Decrease) in Accrued Liabilities 4 month | Increase (Decrease) in Accrued Liabilities 6 month | Increase (Decrease) in Accrued Liabilities 7 month | Increase (Decrease) in Accrued Liabilities 9 month | Increase (Decrease) in Accrued Liabilities 12 month |
|---|---|---|---|---|---|---|---|
| 2022-12-31 | $207.88K derived: 10-K 12 month − 10-Q 9 month · filed 2023-01-25 | $439.82K derived: sum of 2 quarters · filed 2023-01-25 | $1.16M derived: sum of 3 quarters · filed 2023-01-25 | $1.35M 10-K · filed 2023-01-25 | |||
| 2022-09-30 | $231.95K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $956.02K derived: sum of 2 quarters · filed 2022-11-14 | $1.14M 10-Q · filed 2022-11-14 | $1.14M derived: sum of 4 quarters · filed 2023-01-25 | |||
| 2022-06-30 | $724.07K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-15 | $912.85K 10-Q · filed 2022-08-15 | $911.83K derived: sum of 3 quarters · filed 2023-01-25 | $841.44K derived: sum of 4 quarters · filed 2023-01-25 | |||
| 2022-03-31 | $188.78K 10-Q · filed 2022-05-13 | $187.76K derived: sum of 2 quarters · filed 2023-01-25 | $117.37K derived: sum of 3 quarters · filed 2023-01-25 | $123.03K derived: sum of 4 quarters · filed 2023-01-25 | |||
| 2021-12-31 | -$1.02K derived: 10-K 12 month − 10-Q 9 month · filed 2023-01-25 | -$71.41K derived: sum of 2 quarters · filed 2023-01-25 | -$65.75K derived: sum of 3 quarters · filed 2023-01-25 | -$60.99K 10-K · filed 2023-01-25 | |||
| 2021-09-30 | -$70.39K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | -$64.73K derived: sum of 2 quarters · filed 2022-11-14 | -$59.97K 10-Q · filed 2022-11-14 | ||||
| 2021-06-30 | $5.65K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-15 | $10.41K 10-Q · filed 2022-08-15 | |||||
| 2021-03-31 | $4.76K 10-Q · filed 2022-05-13 | ||||||
| 2020-12-31 | $30.15K 10-K/A · filed 2022-03-31 | ||||||
| 2020-09-30 | -$5.00K 10-Q/A · filed 2022-03-31 | ||||||
| 2020-06-30 | $15.21K 10-Q · filed 2021-08-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SHOULDER INNOVATIONS, INC. (SI) | United States | $0.355B | |
| Orthofix Medical Inc. (OFIX) | $0.373B | ||
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| CARLSMED, INC. (CARL) | United States | $0.405B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |